Dexamethasone for the prophylaxis of radiation-induced emesis: A national cancer institute of canada clinical trials group phase III study

Journal of Clinical Oncology

Volumn 18, Issue 9, 2000, Pages 1960-1966

  Kirkbride, Peter ^a   Bezjak, A ^a   Pater, J ^a   Zee, B ^a   Palmer, M J ^a   Wong, R ^a   Cross, P ^a   Gulavita, S ^a   Blood, P ^a   Sun, A ^a   Dundas, G ^a   Ganguly, P K ^a   Lim, J ^a   Chowdhury, A D ^a   Kumar, S E ^a   Dar, A R ^a  

^a Queen's Cancer Research Institute   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; PLACEBO;

ADULT; AGED; ARTICLE; CANADA; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RADIATION SICKNESS; RANDOMIZED CONTROLLED TRIAL; VOMITING;

EID: 0034014924     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.9.1960     Document Type: Article

References (12)

1. Gralla RJ, Osoba D, Kris MG, et al: Recommendations for the use of antiemetics: Evidence-based, clinical practice guidelines. J Clin Oncol 17:2971-2994, 1999
2. Priestman TJ, Roberts JT, Upadhyaya BK: A prospective randomized double-blind trial comparing ondansetron versus prochlorperazine for the prevention of nausea and vomiting in patients undergoing fractionated radiotherapy. J Clin Oncol 5:358-363, 1993
3. Franzen L, Nyman J, Hagberg H, et al: A randomized placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy. Ann Oncol 7:587-592, 1996
4. Sagar SM: The current role of anti-emetic drugs in oncology: A recent revolution in patient symptom control. Cancer Treat Rev 18:95-135, 1991
5. Aaronson N: The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376, 1993
6. Fyles AW, Dembo AJ, Bush RS, et al: Analysis of complications in patients treated with abdomino-pelvic radiation therapy for ovarian carcinoma. Int J Radiat Oncol Biol Phys 22:847-851, 1992
7. Withers HR, Taylor JMG, Maciejewski B: The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27:98-113, 1988
8. Markman M, Scheider V, Ettinger DS: Antiemetic efficacy of dexamethasone. N Engl J Med 311:549-552, 1991
9. Jones AL, Hill AS, Soukop M, et al: Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy. Lancet 338:483-487, 1991
10. The Italian Group: The Italian Group for Antiemetic Research: Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. N Engl J Med 332:1-5, 1995
11. Roila F, Tonato M, Cognetti F, et al: Prevention of cisplatin-induced emesis: A double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone. J Clin Oncol 9:675-678, 1991
12. Bruera E, Roca E, Cedaro L, et al: Action of oral methylprednisolone in terminal cancer patients: A prospective randomized double-blind study. Cancer Treat Rep 69:751-754, 1985